Starting August 1st, 2024, Eurobio Scientific is manufacturing and selling IVD kits for: EndoPredict® (Breast Cancer) / Prolaris® (Prostate Cancer) Read more
The EndoPredict Breast Cancer Prognostic Test is the only second generation gene expression test validated for premenopausal AND postmenopausal women with early-stage ER positive/HER2 negative breast cancer.
Fill out the form below to download your free copy of the premenopausal clinical summary and learn more about this key validation study.